"Diphtheria Toxoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment.
| Descriptor ID |
D004168
|
| MeSH Number(s) |
D20.215.894.691.263
|
| Concept/Terms |
Diphtheria Toxoid- Diphtheria Toxoid
- Toxoid, Diphtheria
- Diphtheria Vaccine
- Vaccine, Diphtheria
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria Toxoid".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria Toxoid".
This graph shows the total number of publications written about "Diphtheria Toxoid" by people in this website by year, and whether "Diphtheria Toxoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria Toxoid" by people in Profiles.
-
Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia. PLoS One. 2021; 16(10):e0258529.
-
Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods. 2006 Feb; 38(2):96-105.
-
Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. J Infect Dis. 1995 Jan; 171(1):99-105.
-
Interferon-gamma and interleukin-6 augment the human in vitro antibody response to the Haemophilus influenzae type b polysaccharide. J Infect Dis. 1992 Jun; 165 Suppl 1:S161-2.
-
In vitro activation of human T lymphocytes by Haemophilus influenzae type b capsular polysaccharides. Scand J Immunol. 1992 Feb; 35(2):137-48.
-
In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate. J Immunol. 1991 Dec 15; 147(12):4192-9.
-
Haemophilus influenzae type B conjugate vaccines. Pediatr Ann. 1990 Dec; 19(12):712-3, 716-8.
-
Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections. J Pediatr. 1988 Aug; 113(2):272-7.
-
Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b. Pediatr Infect Dis J. 1988 Mar; 7(3):156-9.
-
Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest. 1986 Oct; 78(4):959-67.